(Post-pandemic Era)-Global Companion Diagnostic Technologies Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2026
- Report Code : XYZ2131683
- Published On: Nov, 2020
- Category : Medical Devices
- Pages : 103
-
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. Research team published a report for global Companion Diagnostic Technologies market in this environment.
In terms of revenue, this research report indicated that the global Companion Diagnostic Technologies market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Companion Diagnostic Technologies industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The Dako (Agilent Technologies) aims at producing XX Companion Diagnostic Technologies in 2020, with XX % production to take place in global market, Qiagen accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Companion Diagnostic Technologies Market Include by
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Companion Diagnostic Technologies Market
Dako (Agilent Technologies)
Qiagen
Roche
Abbott Laboratories
Ventana Medical Systems
bioMerieux
Myriad Genetics
Resonance Health
Leica Microsystems
Life Technologies
Major Type of Companion Diagnostic Technologies Covered in report:
Immunohistochemistry
Molecular Diagnostics
Application Segments Covered in report
Oncology
Cardiovascular
Central Nervous System
Auto immune & Inflammation
Virology
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
-
With tables and figures helping analyze worldwide (Post pandemic Era) Global Companion Diagnostic Technologies market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Global Companion Diagnostic Technologies Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope1.1 Product Details and Introduction
1.1.1 Immunohistochemistry -Product Introduction and Major Manufacturers
1.1.2 Molecular Diagnostics -Product Introduction and Major Manufacturers1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Companion Diagnostic Technologies Market Assessment, by Segmentation2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026)
2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026)
3 Regional Market Analysis3.1 China Companion Diagnostic Technologies Market
3.1.1 Top Companies leading Companion Diagnostic Technologies Development in China (2015-2020)
3.1.2 Sales Value of Major Company in China Market (2015-2020)
3.1.3 China Companion Diagnostic Technologies Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2015-2026)3.2 EU Companion Diagnostic Technologies Market
3.2.1 Top Companies leading Companion Diagnostic Technologies Development in EU (2015-2020)
3.2.2 Sales Value of Major Company in EU Market (2015-2020)
3.2.3 EU Companion Diagnostic Technologies Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2015-2026)3.3 USA Companion Diagnostic Technologies Market
3.3.1 Top Companies leading Companion Diagnostic Technologies Development in USA (2015-2020)
3.3.2 Sales Value of Major Company in USA Market (2015-2020)
3.3.3 USA Companion Diagnostic Technologies Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2015-2026)3.4 Japan Companion Diagnostic Technologies Market
3.4.1 Top Companies leading Companion Diagnostic Technologies Development in Japan (2015-2020)
3.4.2 Sales Value of Major Company in Japan Market (2015-2020)
3.4.3 Japan Companion Diagnostic Technologies Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2015-2026)3.5 India Companion Diagnostic Technologies Market
3.5.1 Top Companies leading Companion Diagnostic Technologies Development in India (2015-2020)
3.5.2 Sales Value of Major Company in India Market (2015-2020)
3.5.3 India Companion Diagnostic Technologies Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2015-2026)3.6 Southeast Asia Companion Diagnostic Technologies Market
3.6.1 Top Companies leading Companion Diagnostic Technologies Development in Southeast Asia (2015-2020)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020)
3.6.3 Southeast Asia Companion Diagnostic Technologies Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2015-2026)
3.7 South America Companion Diagnostic Technologies Market
3.7.1 Top Companies leading Companion Diagnostic Technologies Development in South America (2015-2020)
3.7.2 Sales Value of Major Company in South America Market (2015-2020)
3.7.3 South America Companion Diagnostic Technologies Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2015-2026)
4 Value Chain (Impact of COVID-19)4.1 Companion Diagnostic Technologies Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream4.2 COVID-19 Impact on Companion Diagnostic Technologies Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2026)5.1 Global Companion Diagnostic Technologies Sales and Growth Rate (2021-2026)
5.2 Global Companion Diagnostic Technologies Sales Value and Growth Rate (2021-2026)
6 Companion Diagnostic Technologies Competitive Analysis6.1 Dako (Agilent Technologies)
6.1.1 Dako (Agilent Technologies) Company Profiles
6.1.2 Dako (Agilent Technologies) Product Introduction
6.1.3 Dako (Agilent Technologies) Companion Diagnostic Technologies Production, Revenue (2015-2020)
6.1.4 SWOT Analysis6.2 Qiagen
6.2.1 Qiagen Company Profiles
6.2.2 Qiagen Product Introduction
6.2.3 Qiagen Companion Diagnostic Technologies Production, Revenue (2015-2020)
6.2.4 SWOT Analysis6.3 Roche
6.3.1 Roche Company Profiles
6.3.2 Roche Product Introduction
6.3.3 Roche Companion Diagnostic Technologies Production, Revenue (2015-2020)
6.3.4 SWOT Analysis6.4 Abbott Laboratories
6.4.1 Abbott Laboratories Company Profiles
6.4.2 Abbott Laboratories Product Introduction
6.4.3 Abbott Laboratories Companion Diagnostic Technologies Production, Revenue (2015-2020)
6.4.4 SWOT Analysis6.5 Ventana Medical Systems
6.5.1 Ventana Medical Systems Company Profiles
6.5.2 Ventana Medical Systems Product Introduction
6.5.3 Ventana Medical Systems Companion Diagnostic Technologies Production, Revenue (2015-2020)
6.5.4 SWOT Analysis6.6 bioMerieux
6.6.1 bioMerieux Company Profiles
6.6.2 bioMerieux Product Introduction
6.6.3 bioMerieux Companion Diagnostic Technologies Production, Revenue (2015-2020)
6.6.4 SWOT Analysis
6.7 Myriad Genetics
6.7.1 Myriad Genetics Company Profiles
6.7.2 Myriad Genetics Product Introduction
6.7.3 Myriad Genetics Companion Diagnostic Technologies Production, Revenue (2015-2020)
6.7.4 SWOT Analysis
6.8 Resonance Health
6.8.1 Resonance Health Company Profiles
6.8.2 Resonance Health Product Introduction
6.8.3 Resonance Health Companion Diagnostic Technologies Production, Revenue (2015-2020)
6.8.4 SWOT Analysis
6.9 Leica Microsystems
6.9.1 Leica Microsystems Company Profiles
6.9.2 Leica Microsystems Product Introduction
6.9.3 Leica Microsystems Companion Diagnostic Technologies Production, Revenue (2015-2020)
6.9.4 SWOT Analysis6.10 Life Technologies
6.10.1 Life Technologies Company Profiles
6.10.2 Life Technologies Product Introduction
6.10.3 Life Technologies Companion Diagnostic Technologies Production, Revenue (2015-2020)
6.10.4 SWOT Analysis
7 Conclusion
-
The (Post pandemic Era) Global Companion Diagnostic Technologies Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
New players are entering the (Post pandemic Era) Global Companion Diagnostic Technologies Market, while established companies are changing their business models and strategies. This pattern is likely to continue for the foreseeable future.
According to the report, the (Post pandemic Era) Global Companion Diagnostic Technologies Industry will grow to USD XXX Million by 2030, with a YY% CAGR.
The (Post pandemic Era) Global Companion Diagnostic Technologies Market research study aids businesses in strategic planning so that they may realize and gain business value from their growth strategies.
The (Post pandemic Era) Global Companion Diagnostic Technologies study focuses on shifting market dynamics, geopolitical and regulatory regulations, and key players' strategies to carefully analyze demand at risk across multiple industry categories.
